| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.09 |
| mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.09 |
| mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.09 |
| mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
0.057 |
0.09 |
| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
| mRNA |
Cyclopamine |
FIMM |
pan-cancer |
AAC |
0.24 |
0.1 |
| mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.1 |
| mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
-0.061 |
0.1 |
| mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.1 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.1 |